RARCET‑L Tablets combine Levocetirizine 5 mg and Montelukast 10 mg, offering fast and sustained relief from allergic symptoms such as sneezing, runny nose, nasal congestion, and itching.
RARCET‑LM™ is indicated for:
Allergic rhinitis (seasonal and perennial)
Chronic urticaria (hives)
Sneezing, nasal congestion, and runny nose
Itchy or watery eyes
Asthma with allergic triggers (as adjunct therapy)
Night-time allergy-related discomfort
Levocetirizine Dihydrochloride IP: 5 mg
Montelukast Sodium IP (equivalent to Montelukast): 10 mg
RARCET‑LM™ is a dual-action anti-allergic formulation that addresses both histamine- and leukotriene-mediated allergy pathways, providing broad and long-lasting symptom control.
Levocetirizine is a non-sedating antihistamine that blocks H1 receptors, effectively relieving symptoms like sneezing, itching, nasal discharge, and eye irritation without affecting mental alertness.
Montelukast is a leukotriene receptor antagonist (LTRA) that reduces airway inflammation and bronchoconstriction, especially helpful in allergic rhinitis patients with mild asthma or nocturnal symptoms.
Together, they offer a convenient once-daily therapy that reduces allergic responses and improves quality of life in allergy-prone individuals.
